Beta glucan: health benefits in obesity and metabolic syndrome
- PMID: 22187640
- PMCID: PMC3236515
- DOI: 10.1155/2012/851362
Beta glucan: health benefits in obesity and metabolic syndrome
Abstract
Despite the lack of international agreement regarding the definition and classification of fiber, there is established evidence on the role of dietary fibers in obesity and metabolic syndrome. Beta glucan (β-glucan) is a soluble fiber readily available from oat and barley grains that has been gaining interest due to its multiple functional and bioactive properties. Its beneficial role in insulin resistance, dyslipidemia, hypertension, and obesity is being continuously documented. The fermentability of β-glucans and their ability to form highly viscous solutions in the human gut may constitute the basis of their health benefits. Consequently, the applicability of β-glucan as a food ingredient is being widely considered with the dual purposes of increasing the fiber content of food products and enhancing their health properties. Therefore, this paper explores the role of β-glucans in the prevention and treatment of characteristics of the metabolic syndrome, their underlying mechanisms of action, and their potential in food applications.
References
-
- World Health Organization: Obesity and overweight: Fact Sheet, http://www.who.int/hpr/NPH/docs/gs_obesity.pdf.
-
- Fujioka K. Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options. Obesity Research. 2002;10(2) - PubMed
-
- Torpy JM, Lynm C, Glass RM. JAMA patient page. The metabolic syndrome. Journal of the American Medical Association. 2006;295(7):p. 850. - PubMed
-
- Vrolix R, Mensink RP. Effects of glycemic load on metabolic risk markers in subjects at increased risk of developing metabolic syndrome. The American Journal of Clinical Nutrition. 2010;92(2):366–374. - PubMed
-
- Esposito K, Marfella R, Ciotola M, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. Journal of the American Medical Association. 2004;292(12):1440–1446. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
